Radiation Dose in Humans From Orally Administered Tc99m-Heparin

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

September 30, 2020

Study Completion Date

October 31, 2020

Conditions
Eosinophilic Esophagitis
Interventions
RADIATION

Computerized Tomography scan

imaging scan from a person's eyes to their thighs

RADIATION

Single Photon Emission Computed Tomography scans

imaging scan taken during, and after, the administration of the radioactive agent

DRUG

Technetium Tc 99M

subjects are administered radioactive heparin as part of study participation.

RADIATION

Planar Images

2 dimensional imaging - whole body planar scans

PROCEDURE

Esophagogastroduodenoscopy

esophagogastroduodenoscopy with tissue biopsies

Trial Locations (1)

84132

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT04069429 - Radiation Dose in Humans From Orally Administered Tc99m-Heparin | Biotech Hunter | Biotech Hunter